Potent and selective glutamyl-prolyl-tRNA synthetase inhibitor (Ki=18.3 nM) derived from the natural product febrifugine. Exhibits little toxicity at concentrations (<10 µM) that reduce TMPRSS2 protein levels via enhanced ubiquitination and proteasomal degradation. Also attenuates TGF-β...
Know who made it. See the evidence. Buy through one marketplace.
Potent and selective glutamyl-prolyl-tRNA synthetase inhibitor (Ki=18.3 nM) derived from the natural product febrifugine. Exhibits little toxicity at concentrations (<10 µM) that reduce TMPRSS2 protein levels via enhanced ubiquitination and proteasomal degradation. Also attenuates TGF-β signaling, including reversibly reducing Smad3 protein and phosphorylation levels. Blocks fibrosis, angiogenesis, and tumor progression, as well as differentiation of TH17 immune cells. Simultaneously activates the Integrated Stress Response (ISR) and mTOR signaling in mouse embryo fibroblasts
This product is manufactured by TriBio Science and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
